This study investigated the performance of ART eligibility criteria in pregnant and postpartum women in resource-limited settings, and found that use of CD4+ cell count criterion is superior to clinical staging in identifying pregnant and postpartum HIV+ women eligible for ART.
The original article by Carter et al. (2010) is located online in the Journal of Acquired Immune Deficiency Syndromes at: http://journals.lww.com/jaids/Fulltext/2010/11010/CD4__Cell_Count_Testing_More_Effective_Than_HIV.19.aspx
Please Sign in (or Register) to view further.